Share on

Global Cytokine Based Therapies and Inhibitors Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Type, Therapeutic Application & Region - Industry Forecast (2023 to 2028)

Published: March, 2023
ID: 7991
Pages: 175
Formats: report pdf report excel report power bi report ppt

Cytokine-Based Therapies and Inhibitors Market Size (2023 to 2028)

The size of the global cytokine-based therapies and inhibitors market is estimated to grow at a healthy CAGR during the forecast period.

Cytokines are the molecular messengers that allow communication with the immune system cells to generate a coordinated, robust but self-limited response to the targeted antigen. Cytokines provide various benefits; unlike chemical drugs, a specific protein that mediates the inflammatory process can be inhibited.  Cytokine inhibitors include antagonists, soluble receptors, cytokine-binding proteins, and the cytokine that blocks other cytokines. The treatment for immune-mediated medical illnesses, including cancer and viral infections, can be done using Immunomodulatory, anti-viral, antiproliferative properties, cytokine interferon-alpha interleukin (IL). The cytokine-based therapies can provide novel treatments for cancer, autoimmune diseases, and many types of infectious diseases. Various factors have limited the clinical potential of cytokines as drugs. FDA   partnership was made with the New York Academy of Sciences to host a forum to discuss practical ways to harness the clinical potential of cytokines and cytokine antagonists as therapeutic agents.

MARKET DRIVERS:

Cytokine-based therapies have the potential to provide treatments for autoimmune diseases and cancer. Intercellular messengers activate signaling pathways in virtually all cell types. Rising research and development for understanding the mechanics and technological advancements in the immunological and therapeutics applications are anticipated to propel the market growth of the cytokine-based Therapies and Inhibitors Market. Increasing interest in harnessing the immune system to eradicate cancer will crease demand for the market. Vast signaling networks to develop cancer treatments are expected to raise market growth. Several animal tumor model studies have displayed that cytokines have a broad anti-tumor activity translated into several cytokine-based approaches for cancer therapy which is expected to drive market growth. Cytokines are finding growing acceptance in cancer therapy all over the world. 

MARKET RESTRAINTS:

The Cytokine Based Therapies and Inhibitors Market has some restraining factors that are restraining market growth, such as the scarcity of skilled professionals for cytokine treatments for autoimmune diseases and cancer across the world; the high cost of therapies is expected to impede the market growth.

Impact of COVID-19 on Cytokine-Based Therapies and Inhibitors Market:

The covid-19 is a global pandemic that was first identified in Wuhan, China. The world health organization announced COVID-19 as the emergence of healthcare. It is an infectious disease that spreads quickly from person to person. All the governments had declared nationwide lockdown and a ban on transportation and flights to control the spread. COVID-19 disrupted the global economy in an unprecedented way. Many country's government authorities have imposed lockdown restrictions that disturbed the supply chain and manufacturing units with the coronavirus's surging cases. However, the current evidence represents that severely ill patients tend to have a high concentration of proinflammatory cytokines. The high level of cytokines also shows a poor prognosis in COVID-19. Also, excessive infiltration of proinflammatory cells, including macrophages and T-helper 17 cells, has been found in lung tissues of coronavirus patients by post-mortem examination. As per the reports, cytokine storms may contribute to the mortality of COVID-19.  The cytokines-based therapies and inhibitors market is anticipated to witness higher growth in the forecast period.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2022 to 2028

Base Year

2022

Forecast Period

2023 to 2028

Segments Covered

By Type, Therapeutic Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global cytokine-based therapies and inhibitors market has been segmented and sub-segmented based on the type, therapeutic application, and region.

Cytokine-Based Therapies and Inhibitors Market – By Type:

  • Interleukins            
  • Tumor necrosis factor        
  • Epidermal growth factor   
  • Interferon               
  • Chemokine    

Based on the type, the interleukins segment is expected to dominate the global cytokine-based therapies and inhibitors market during the forecast period. Interleukins are a group of cytokines that were first seen to be expressed by white blood cells. Interleukins regulate cell growth, differentiation, and mobility, which are essential in stimulating immune responses like inflammation. The increasing global prevalence of autoimmune disorders, increasing geriatric population, and advanced technologies in novel interleukins inhibitors are projected to increase the market growth.

Cytokine-Based Therapies and Inhibitors Market – By Therapeutic Application:

  • Inflammatory and immune disorders          
  • Cancer and malignancies   
  • Infectious diseases              
  • Others      

Based on the therapeutic application, the inflammatory and immune disorders segment accounted for the largest share in the global market during the forecast period. The sign of an autoimmune disease is inflammation which causes redness, pain, and swelling. The disorders also have flare-ups when they get worse and are in remission. An increase in the autoimmune system incidence, a rise in the adoption of autoimmune disease therapeutics, and growing R&D activities to develop ideal therapeutics are the major driving factors of the inflammatory and immune disorders market.

Cytokine-Based Therapies and Inhibitors Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America leads the global cytokine-based therapies and inhibitors market due to many companies in Cytokine Based Therapies and Inhibitors and increasing government investments. The North American Cytokine Based Therapies and Inhibitors Market growth is majorly driven by the factors such as the increasing prevalence of cancer. According to the American cancer society, it was estimated there were 1,762,450 new cancer cases and 606,880 diagnosed cancer deaths in the United States, which are anticipated to rise in the future. Moreover, increasing R&D activities of cancer therapies with lesser side effects are expected to create demand for cytokine-based treatments through which market expansion is possible.

In 2022, the European market accounted for a substantial share globally and was estimated to register a healthy CAGR during the market forecast period. The market growth can be increased by the factors such as growing interest among people in harnessing the immune system to eradicate cancer.

The Asia Pacific is the fastest-growing market segment due to the growing awareness and increasing collaborations with western companies in China and the well-established biotechnology industries in Japan.

The Latin American market is expected to have steady growth with an increasing compound annual growth rate (CAGR). The players are technological advancements in immunological and therapeutics applications and are anticipated to propel cytokine-based market growth.

Middle East Africa held a moderate share of the Cytokine Based Therapies and Inhibitors Market. The market had a portion of the global market in 2020. However, Middle East Africa is projected to increase its growth during the forecast period.

KEY MARKET PARTICIPANTS:

Some of the prominent companies leading the global cytokine-based therapies and inhibitors market profiled in this report are GlaxoSmithKline LLC, AbbVie Inc., Eli Lilly and Company, Genentech, Inc., Immunochemistry Technologies LLC, Roche Diagnostics, Novartis, Merck Sharp & Dohme Corp., Johnson & Johnson, and Amgen Inc.

Please wait. . . . Your request is being processed

FAQ's

What is driving the growth of the cytokine-based therapies and inhibitors market?

The growing prevalence of autoimmune diseases, cancer, and infectious diseases, as well as advancements in cytokine-based drug development boost the market growth.

Who are the key players in the cytokine-based therapies and inhibitors market?

AbbVie Inc., Amgen Inc., AstraZeneca plc, Bristol Myers Squibb Company, Novartis AG, Pfizer Inc., and Roche Holding AG are some of the major companies in the market.

Which region had the largest share of the cytokine based therapies and inhibitors market in 2022?

North America is the largest market for cytokine-based therapies and inhibitors, followed by Europe and Asia Pacific.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample